about
Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled studyImmunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosisNew aspects in the management of pneumoniaCiprofloxacin modulates cytokine/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound traumaProphylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapyEffect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosisHigh-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones.Leukoencephalopathy resolution after atypical mycobacterial treatment: a case reportImmune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune SystemAntibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of lifeEffect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Moxifloxacin modulates inflammation during murine pneumonia.Ciprofloxacin as a potential radio-sensitizer to tumor cells and a radio-protectant for normal cells: differential effects on γ-H2AX formation, p53 phosphorylation, Bcl-2 production, and cell deathAntimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines.Effects of awakening and the use of topical dexamethasone and levofloxacin on the cytokine levels in tears following corneal transplantationHost gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infectionChoosing the right combination therapy in severe community-acquired pneumoniaEffect of moxifloxacin combined with cefotaxime compared to cefotaxime-gentamicin combination on prevention of white matter damage associated with Escherichia coli sepsis in neonatal rats.Ciprofloxacin enhances stress erythropoiesis in spleen and increases survival after whole-body irradiation combined with skin-wound traumaSynergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatusPleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung InjurySubinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunityVirulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescenceComparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin.Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon EpitheliaSystemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody.
P2860
Q24604509-62F45BA6-B0E7-47F2-8404-CFA96C31D0D2Q26778064-56A66426-8128-4EFC-8658-D12B3B349F29Q28080025-F80BD88C-840F-4CE2-9681-EA35C485CD8FQ28487821-A2212527-7EDD-4394-8D00-C11F04F050D4Q28571264-CDC8650F-9B4A-4A56-A540-ECF5C8C41B4EQ28729980-9E308D08-5BD6-456F-9B7F-0741D57DD3FAQ30888166-A285B2EC-90BC-4938-90DA-5A1F45072D1CQ30991042-8E0B5A02-BEC7-4499-B2B1-CAEE902DFE9EQ33575993-F7C07CEF-6F86-441B-BDD2-F651718C596BQ33639134-7342EE80-B6AC-4126-B14C-00CEC8560A97Q33664362-06E837EF-40CF-49EB-B9BC-F7A207C5033FQ33755801-3542E276-5D90-47A3-AA78-C2149C02CB57Q33935218-211B6A68-D918-4793-B747-5472B0A8A09CQ33983140-7213E187-9A33-472A-9A68-7AFA28208205Q33986123-9ADB22D8-6365-410E-9BF6-90394EDA4BBAQ34004301-A9D8683D-4363-4A8D-B0FC-EA741C2CD061Q34058316-93C22EAF-BFA4-44B1-A9C0-E05260F15859Q34159593-B19B14E5-353F-4DF5-9456-1F58ECFE42E5Q34297656-ADC12B40-9CEC-4D90-8A2C-73ABEFFC2278Q34368520-358A6AC0-0922-4F2C-ABE0-0519E48BAE71Q34395559-7AA9AA46-4387-4871-8673-EBF4A8B88139Q34406481-57A90CFA-52F1-4916-A762-84CC0A4C9A06Q34658467-9A59280D-E956-4A63-B204-53F4E222F4F4Q34981779-AA9343DA-BDCC-4129-9F33-363A66CA1132Q34999131-7F635D53-9025-47EE-A94B-902195710FD3Q35065880-4DFF7D1C-C792-4861-9B4F-B3005FC05D31Q35109069-9E0D4945-CA72-4A07-8A91-0F9BA21D6991Q35598556-B2E312DE-7C26-4AFD-BE1A-7CA4AC042572Q35666900-FF9EE367-1940-498E-9B0F-E62C44E8FE12Q35677483-19801D5B-AA24-459F-8546-5A75B15FD3F7Q35867280-199F7A09-B4EF-413D-B390-A3CC148F4D37Q36295507-1E449700-69F9-402F-8E44-ADCFD724F86BQ36337074-E667AEE9-2014-473A-B090-1F3D505D1D59Q36406243-B6E180DC-F6EE-4C37-9B15-1D84024AC9EFQ36505493-65EBD51D-618E-471C-8D31-0E6BBF835E1BQ36669130-BC2C4875-4D2A-4C1C-ACD4-205B22B33504Q36683648-89242232-6C12-422F-B4E7-B0326D1D83D4Q36744785-9832FD70-4279-42FB-9AF8-6978C9AC8039Q37071001-AA57A807-DA84-43C5-9BF4-BF678B0F5371Q37071964-41502AFB-24F3-4D04-80E1-FDC81FD95D50
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunomodulatory effects of quinolones.
@ast
Immunomodulatory effects of quinolones.
@en
type
label
Immunomodulatory effects of quinolones.
@ast
Immunomodulatory effects of quinolones.
@en
prefLabel
Immunomodulatory effects of quinolones.
@ast
Immunomodulatory effects of quinolones.
@en
P1476
Immunomodulatory effects of quinolones.
@en
P2093
Axel Dalhoff
Itamar Shalit
P304
P356
10.1016/S1473-3099(03)00658-3
P577
2003-06-01T00:00:00Z